Get the Stockscreener App
5.93
0.17%
0.010
Sanuwave Health Inc stock is traded at $5.93, with a volume of 109.46K.
It is up +0.17% in the last 24 hours and down -30.81% over the past month.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
See More
Previous Close:
$5.92
Open:
$5.9
24h Volume:
109.46K
Relative Volume:
0.56
Market Cap:
$50.99M
Revenue:
$44.33M
Net Income/Loss:
$16.05M
P/E Ratio:
18.14
EPS:
0.3269
Net Cash Flow:
$3.85M
1W Performance:
-7.20%
1M Performance:
-30.81%
6M Performance:
-77.70%
1Y Performance:
-83.87%
1-Day Range:
$5.82
$6.16
1-Week Range:
$5.77
$6.60
52-Week Range:
$5.77
$46.59
Sanuwave Health Inc Stock (SNWV) Company Profile
Name
Sanuwave Health Inc
Sector
Industry
Phone
952-656-1029
Address
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.79 | 404.28M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.39 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.115 | 270.26M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
46.71 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
115.41 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Northland Capital | Outperform |
| Jul-29-25 | Initiated | Roth Capital | Buy |
Sanuwave Health Inc Stock (SNWV) Latest News
Calendrier des PAPE pour: - Yahoo Finance France
What's going on with SANUWAVE Health stock on Friday? - MSN
Sanuwave Q2 revenue exceeds revised guidance on record consumable sales - scanx.trade
What's Going On With SANUWAVE Health Stock On Friday? - Benzinga
SANUWAVE Health (SNWV) Stock Forum and Discussion - Moomoo
Sanuwave sees Q2 revenue up to $9.8M - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance - Ortho Spine News
Sanuwave Health preliminary revenue increases up to 5% in Q2 2026 - Medical Buyer
Sanuwave Health (SNWV) Raises Q2 Revenue Expectations to $9.6M-$9.8M - GuruFocus
Sanuwave Health Reports Q2 2026 Revenue Above Guidance Amid Record Consumable Sales and Used System Market Growth - Minichart
Sanuwave Health (SNWV) Reports Second Quarter Revenue Expectatio - GuruFocus
Sanuwave Health, Inc. Revises Earnings Guidance for the Second Quarter Ended June 30, 2026 - marketscreener.com
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance By Investing.com - Investing.com Nigeria
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance - Investing.com
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6-$9.8 Million, Above High End of Revised Guidance - The Manila Times
Sanuwave Health Reports Preliminary Second Quarter 2026 Revenue Above Revised Guidance Range - Quiver Quantitative
Press Release: Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6--$9.8 Million, Above High End of Revised Guidance - Moomoo
A Look at SANUWAVE Health Inc (SNWV) After 3.4% Decline -- GF Va - GuruFocus
SANUWAVE Health (SNWV) director granted 5,524 fully vested stock options - Stock Titan
SANUWAVE Health (SNVW) director granted 5,524 $10 options - Stock Titan
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2000 Dynamic Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000E Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell Small Cap Completeness Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2500 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 3000 Growth Benchmark - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Sanuwave Health, Inc. Actuals & Estimates (NASDAQ:SNWV) - TradingView
SNWV Q1 2026 Earnings: Wider-Than-Expected Loss Dampens Investor SentimentAnalyst Drop Coverage - DonanımHaber
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Stock Rises 4.51%EPS Growth Rate - dars.gov.et
SANUWAVE Health (SNWV) Faces Selling Pressure, Tests Key Support After 4.66% DeclineFactor Rotation - dars.gov.et
SNWV Q1 2026 Earnings: Larger-Than-Expected Loss as Revenue Remains UndisclosedProfit Margin Analysis - dars.gov.et
SNWV: UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts - TradingView
Sanuwave Health eyes revenue up to USD 9.5M in Q2 2026 - Medical Buyer
Sanuwave Health expects Q2 revenue of $8.5M-$9.5M - scanx.trade
Top Midday Decliners - Moomoo
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com South Africa
Sanuwave Health, Inc. Updates Earnings guidance for the Second Quarter 2026 - marketscreener.com
Sanuwave Health Cuts Q2 Revenue Guidance Amid Market Pressures - TipRanks
Sanuwave cuts Q2 revenue guidance on weak equipment sales - Investing.com
Sanuwave Health Updates Second Quarter 2026 Guidance - The Manila Times
Sanuwave updates Q2 revenue guidance to $8.5–$9.5M, applicator demand strong despite Ultramist headwinds - TradingView
Press Release: Sanuwave Health Updates Second Quarter 2026 Guidance - Moomoo
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider LossROE Trend Analysis - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
SANUWAVE Health Inc Annual Shareholders Meeting Transcript - GuruFocus
Sanuwave Health Inc Stock (SNWV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sanuwave Health Inc Stock (SNWV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
May 01 '26 |
Sale |
16.11 |
10,581 |
170,465 |
5,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 28 '26 |
Sale |
18.47 |
46,288 |
854,819 |
7,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 29 '26 |
Sale |
17.25 |
24,360 |
420,152 |
6,500 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '26 |
Sale |
20.46 |
16,267 |
332,841 |
10,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 21 '26 |
Sale |
20.50 |
202 |
4,142 |
954,798 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 11 '25 |
Sale |
31.28 |
13,500 |
422,277 |
70,499 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 12 '25 |
Sale |
21.04 |
6,500 |
136,789 |
63,999 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
30.75 |
125,400 |
3,856,050 |
881,390 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 09 '25 |
Sale |
30.58 |
8,785 |
268,679 |
872,605 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 10 '25 |
Sale |
30.39 |
8,625 |
262,129 |
863,980 |
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):